Abizer Harianawala

Title: Abizer Harianawala: Innovating Hepatitis B Treatments

Introduction

Abizer Harianawala is a prominent inventor based in North Brunswick, NJ, who has made significant contributions to the field of pharmaceutical formulation. His work focuses on innovative approaches to treating viral infections, particularly hepatitis B.

Latest Patents

Harianawala holds a patent for a "Low dose entecavir formulation and use." This patent outlines compositions containing a low dose of entecavir, which are administered daily to effectively treat hepatitis B virus infections and associated co-infections. The patent also describes formulations for oral administration that can include other pharmaceutically active substances to enhance treatment outcomes for affected patients.

Career Highlights

Abizer Harianawala is associated with Bristol-Myers Squibb Company, a global leader in biopharmaceuticals. His role at this esteemed institution underscores his commitment to advancing medical science and improving the quality of life for patients suffering from chronic viral infections.

Collaborations

Throughout his career, Harianawala has collaborated with notable coworkers such as Richard Colonno and Omar L. Sprockel. These collaborations reflect a strong team dynamic, aimed at enhancing research and developing groundbreaking healthcare solutions.

Conclusion

With a focus on innovative drug formulations and collaborative efforts within the pharmaceutical industry, Abizer Harianawala continues to be a pivotal figure in the fight against hepatitis B. His work not only contributes to scientific advancements but also offers hope to patients worldwide.